POLEPHARMA
POLEPHARMA is a French (bio)pharmaceutical industrial cluster headquartered in Chartres that connects ~450 member companies — pharma labs, suppliers, and research institutions — through working groups, three annual congresses, multi-city training programs, and the Parcours Pharma digital orientation platform.
- Company typePrivate
- Founded2001
- HeadquartersChartres, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What POLEPHARMA does
POLEPHARMA is a French cooperative cluster (association loi 1901) founded around 2001 and headquartered in Chartres, France, that structures and supports the industrial (bio)pharmaceutical sector across France. It connects approximately 450 member organizations — pharmaceutical laboratories (including GSK France, Sanofi, Servier, and Novo Nordisk), equipment and service suppliers, higher education and research institutions, professional collectives, and individual experts — into a shared platform for mutualization of needs, know-how, and solutions. Its core offerings span four pillars: (1) Intelligence Industrielle, comprising eight working groups covering Quality Assurance, Quality Control, Supply, Qualification/Validation, Environmental Performance, Data Lifecycle, AI, and Responsible Pharmacist topics; (2) Emploi, including a job board, CV repository, and the Parcours Pharma digital orientation tool built with IMT and the Normandie Region; (3) #LaFabrique, a multi-city professional training program covering pharmaceutical affairs, industrial performance, HR, commercial performance, management, and communication, delivered in Paris, Chartres, Louviers, Bordeaux, Tours, and Lyon; and (4) three flagship annual congresses — Biotesting, Industrie du Futur, and Performance Environnementale — each attracting 135-250+ decision-makers. Strategic and institutional partners include the Normandie Region, France Biolead, SFSTP, IMT, IDEC Santé, and major metropolitan authorities.
The business model is a hybrid of recurring membership subscriptions from ~450 member companies, tiered congress/event ticketing (member vs. non-member, with categories for ETI/Group, SME, Start-Up, Academic, and Student), and professional services revenue from training. Distribution is primarily direct and community-led: working groups, congresses, TecLabs workshops, and webinars, complemented by a digital platform (Parcours Pharma) for self-service career orientation. Geographically the cluster operates nationwide across France with regional anchors in Chartres (Centre-Val de Loire), Rouen/Louviers (Normandie), and Lyon-Rhône-Alpes. There are no public revenue figures, no disclosed funding rounds, no M&A activity, and no parent company; POLEPHARMA operates as an independent member-funded cooperative.
POLEPHARMA firmographics
Firmographics- Name
- POLEPHARMA
- Legal name
- POLEPHARMA
- Website
- https://polepharma.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- POLEPHARMA is a French (bio)pharmaceutical industrial cluster headquartered in Chartres that connects ~450 member companies — pharma labs, suppliers, and research institutions — through working groups, three annual congresses, multi-city training programs, and the Parcours Pharma digital orientation platform.
- Ownership category
- akta.pro rank
POLEPHARMA industry classification
Industry- Product category
- Pharmaceutical Industry Cluster Services
- NAICS
- Business Associations (81391)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)
- akta.pro secondary industry
- Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO)
Keywords
Where POLEPHARMA is headquartered
LocationHeadquarters
- HQ city
- Chartres
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
POLEPHARMA business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Membership Fees: POLEPHARMA generates revenue through membership fees from its 450+ member companies including pharmaceutical laboratories, suppliers, research institutions, and other stakeholders in the pharmaceutical industrial sector. The membership fee structure is detailed in the 'Grille de cotisation' document available to prospective members.
- Congress and Event Fees: Revenue from ticketing fees for annual congresses (Polepharma Biotesting, Industrie du Futur, Performance Environnementale) and other professional events. Different pricing tiers exist for POLEPHARMA members, SFSTP members, and non-members, with categories for ETI/Group, PME, Start-Up, Academic, and Student attendees.
- Training Programs (#LaFabrique): Revenue from professional training programs offered through #LaFabrique, covering pharmaceutical affairs, industrial performance, human resources, commercial performance, management, personal development, and communication. Training locations include Paris, Chartres, Louviers, Bordeaux, Tours, and Lyon.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Polepharma Member Congress Ticket - various sizes |
| Subscription | Pay-as-you-go | Non-Member Congress Ticket |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
POLEPHARMA product offering
Product offeringCore offering
POLEPHARMA operates a French (bio)pharmaceutical industrial cluster that connects 450+ member organizations (pharmaceutical laboratories, suppliers, higher-education and research institutions, collectives, experts) through access-based membership services, eight thematic working groups, three annual congresses (Biotesting, Industrie du Futur, Performance Environnementale), the #LaFabrique professional training catalogue, employment and career-orientation services (including the Parcours Pharma digital tool), and a sector-wide sponsor and partner network.
Product overview
POLEPHARMA is a cluster/organization (not a software product) that structures the French (bio)pharmaceutical industrial sector, operating as a cooperation platform rather than a unified software product. Its offerings include: Intelligence Industrielle (core service with working groups, congresses, workshops, webinars), Emploi (employment services with job platform and Parcours Pharma digital orientation tool), #LaFabrique (training programs in pharmaceutical affairs, industrial performance, HR, management), and three annual congress events (Biotesting, Industrie du Futur, Performance Environnementale). The organization connects pharmaceutical laboratories, suppliers, research institutions, and experts across France through network services, knowledge sharing, and collaborative initiatives.
Differentiator
Problem solved
Functional benefit
Products and services
- Intelligence Industrielle Core POLEPHARMA service covering transverse industrial topics and future issues through working groups on Innovation RH, Promotion de la filière, R&D & Innovation, Performance Industrielle, Affaires pharmaceutiques, Performance Environnementale, Réseau, and Affaires Publiques; includes congresses, workshops, TecLabs, and webinars for member companies.
- #LaFabrique (Professional Training) Professional training catalogue delivered across Paris, Chartres, Louviers, Bordeaux, Tours and Lyon covering pharmaceutical affairs, industrial performance, human resources, commercial performance, management, personal development and communication, targeted at member companies and their staff.
- Parcours Pharma Digital self-guided career orientation solution targeting high-school students, university students, job seekers, career changers and supervisors to provide a personalised pathway into the pharmaceutical industrial sector.
- Emploi (Employment services) Employment service promoting pharmaceutical sector careers and talent employability, organising job fairs, facilitating exchanges between training organisations, employment actors and industrialists, including a job board platform and the Parcours Pharma digital orientation tool.
- Congrès Polepharma Biotesting Annual congress bringing together academic research, clinical, startup, biotech, and pharmaceutical industry decision-makers to discuss Biotesting challenges, analytical innovation for biotherapies and industrial needs.
- Congrès Polepharma Industrie du Futur Annual congress for actors of Technological Transformation of the Pharmaceutical Industry, featuring conferences, practical workshops, experience sharing and networking on industrial performance and the industry of the future.
- Congrès Polepharma Performance Environnementale Annual congress on environmental transition of the pharmaceutical industry addressing climate change adaptation, decarbonation and industrial performance for pharmaceutical production.
Quantifiable outcome
- 450 member companies connected across the French pharmaceutical sector
- +2 more outcomes
Companies that use POLEPHARMA
Customer profileNamed customers9 records
Segments5 records
Ideal customer profiles4 records
POLEPHARMA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
POLEPHARMA partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core and minor.
- Normandie RegioncoreMajor regional partner supporting POLEPHARMA activities and congress events including the Performance Environnementale Congress. Logo displayed prominently on partner page.
- France BioleadcoreNational biotechnology and pharmaceutical leadership organization partner. Collaborative relationship for sector development and innovation.
- SFSTP (Société Française des Sciences et Techniques Pharmaceutiques)coreCo-organizer of congress events (Polepharma-SFSTP). SFSTP federates pharmaceutical sector actors and ensures identification and resolution of industry challenges. Joint promotion of Biotesting and other congresses.
- IMT (Institut Mines-Télécom)corePartner in developing Parcours Pharma digital orientation platform for the pharmaceutical industrial sector. Collaboration with engineering school network for training and innovation.
- IDEC SantécoreDesign and construction partner for pharmaceutical sites. Partner for over 10 years, providing expertise in sustainable pharmaceutical facility design and construction. Active participant in Performance Environnementale Congress.
- ServierminorGold partner for Biotesting Congress 2025.
- SanofiminorGold partner for Biotesting Congress 2025. Major pharmaceutical manufacturer active in congress programming and industry initiatives.
- Clean CellsminorGold partner for Biotesting Congress 2025.
- SOTAX Pharma ServicesminorGold partner for Biotesting Congress 2025.
- Nova BiomedicalminorExhibitor at Biotesting Congress 2025 (stand 17). Provider of cell culture analyzers and cell counting technology.
- CaelisminorGold partner at multiple congresses. French manufacturer of climatic chambers for pharmaceutical industry with expertise in stability, ICH compliance, and environmental conditions.
- EQUANSminorGold partner for Industrie du Futur Congress and Performance Environnementale Congress. Leader in energy and services sector driving decarbonation, digitalization, and industrial reindustrialization.
- VeoliaminorGold partner for Performance Environnementale Congress. Provides industrial water management, effluent treatment, and waste valorization for pharmaceutical sector.
- PwC FranceminorSilver partner for Performance Environnementale Congress. Provides consulting on sustainability regulations, CSRD, and environmental strategy.
- ManergyminorSilver partner for Performance Environnementale Congress. Industrial decarbonation consulting and engineering services.
- CHIMIREC ValrecoiseminorSilver partner for Performance Environnementale Congress. Waste management specialist serving pharmaceutical sector for over 30 years.
- GSKcorePrivilège partner and Congress President for Performance Environnementale Congress. Major pharmaceutical manufacturer with three French sites committed to 80% GHG reduction by 2030.
- ETN ELEC EUROminorPartner at both Industrie du Futur and Performance Environnementale congresses. Electrical equipment distribution group with 58 agencies in France.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
POLEPHARMA competitors and assessment
Company assessmentDirect peers
- Lyonbiopôle (now part of Auvergne-Rhône-Alpes life-sciences cluster): Historic French biocluster for the Lyon/Auvergne-Rhône-Alpes region focused on human and animal health. Comparable to POLEPHARMA as a regional cluster serving French pharma/biotech members with working groups and events.
- Medicen Paris Region: Paris-based life sciences competitiveness cluster; comparable to POLEPHARMA as a French regional cluster organizing industry cooperation, working groups, and events for pharma/biotech members. Already co-runs the IA working group with POLEPHARMA.
- SFSTP (Société Française des Sciences et Techniques Pharmaceutiques): Federation of French pharmaceutical sciences and techniques actors; co-organizes multiple POLEPHARMA congresses (e.g., Polepharma-SFSTP Biotesting). Directly comparable in mission to organize the French pharma industry around scientific exchange and standards.
- Atlanpole Biothérapies: Western-France biotherapy and bioproduction competitiveness cluster headquartered in Nantes. Directly comparable as a French regional pharma/biotech cluster with similar working-group, training, and member-engagement model.
- Eurobiomed: Lead French healthcare/biotech cluster for the Provence-Alpes-Côte d'Azur and Occitanie regions. Directly comparable to POLEPHARMA in structure, mission, and services (working groups, events, member services for life sciences manufacturers and suppliers).
- Cancéropôle CLARA: Oncology-focused competitiveness cluster for the Auvergne-Rhône-Alpes and Clermont-Ferrant regions. Comparable to POLEPHARMA as a French cluster driving pharma/biology industry cooperation, research translation, and member events.
Regional players
- BIOPRO Baden-Württemberg GmbH: Baden-Württemberg's state-level biotech industry network. Directly comparable in cluster model (industry networking, working groups, training, member services) for life sciences actors — geographically scoped to Germany.
- Medicon Valley Alliance: Cross-border life sciences cluster organization for the Denmark-Sweden Medicon Valley region. Comparable to POLEPHARMA as a regional pharma/biotech member-driven cluster organizing events and member services — but serves Scandinavian rather than French territory.
- BioRegio STERN Management GmbH: German life sciences cluster for the Stuttgart/Tübingen/Neckar-Alb region. Comparable to POLEPHARMA as a regional pharma/biotech cluster with member services, working groups, and industry events — but operating in Germany rather than France.
Broad incumbents
- France Biolead: National French biotech and bioproduction leadership organization. POLEPHARMA lists France Biolead as a strategic partner; it operates at a broader national scope than POLEPHARMA, making it a broader incumbent operating in the same French life-sciences cluster category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
POLEPHARMA social profiles
Digital presencePOLEPHARMA financial estimates
Financial estimateRevenue estimate
Valuation estimate
POLEPHARMA leadership team
Management profileNumber of profiles
Profiles11 records
POLEPHARMA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
POLEPHARMA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about POLEPHARMA
What does POLEPHARMA do?
POLEPHARMA operates a French (bio)pharmaceutical industrial cluster that connects 450+ member organizations (pharmaceutical laboratories, suppliers, higher-education and research institutions, collectives, experts) through access-based membership services, eight thematic working groups, three annual congresses (Biotesting, Industrie du Futur, Performance Environnementale), the #LaFabrique professional training catalogue, employment and career-orientation services (including the Parcours Pharma digital tool), and a sector-wide sponsor and partner network.
Is POLEPHARMA a public or private company?
POLEPHARMA is a private company. It is classified as unknown and is currently operating.
When was POLEPHARMA founded?
POLEPHARMA was founded in 2001. It employs 11 to 50 people.
Where is POLEPHARMA based?
POLEPHARMA is headquartered in Chartres, France, in the Europe region.
How does POLEPHARMA make money?
Three revenue lines are on record. Membership Fees are the primary driver. The others are congress and Event Fees and training Programs (#LaFabrique).
Who are POLEPHARMA's main competitors?
Direct peers on record are Lyonbiopôle (now part of Auvergne-Rhône-Alpes life-sciences cluster), Medicen Paris Region, SFSTP (Société Française des Sciences et Techniques Pharmaceutiques), Atlanpole Biothérapies, Eurobiomed and Cancéropôle CLARA. Regional players are BIOPRO Baden-Württemberg GmbH, Medicon Valley Alliance and BioRegio STERN Management GmbH. France Biolead is listed as a broad incumbent.
Does POLEPHARMA have an API?
No public API is recorded for POLEPHARMA.
What industry is POLEPHARMA in?
POLEPHARMA's product category is Pharmaceutical Industry Cluster Services. Its primary akta.pro industry code is HLAGAGAL, GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification), with a secondary code of HLAGAKAO, Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent). Its NAICS code is 81391 and its SIC code is 8600.